Enveric Biosciences, Inc.

US$1.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ENVBHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (82.49%)
Div yield —
ROE (170.04%)
Biotechnology
Beta (5Y) 1.21
PE TTM —
TSR TTM (75.02%)
Mkt cap US$6.374M
ROIC (106.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.71
19.90%
(89.60%)
Buy 10|0|5|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.04
35.00%
34.96%
24.91%
25.35%
Revenue$M
0.338
0.335
0.326
0.317
2.32%
3.68%
3.14%
(4.65%)
Peers (US$6.374M)
Cap (US$)
PE
6.316M
—
Capital
TTM
5Y
10Y
Leveragex
0.546
(0.094)
(0.099)
EBIT/Intx
0.254
0.085
0.090
Own earn%
(71.31)
18.10
15.65
Sh yield%
36.45
30.53
31.09
Owners
Insiders/Inst%
5.18
27.04
Short interest%
3.68
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
7–17
$1 testx
0.1
Incr. ROIC%
0